Author:
Salyers Michelle P.,Mueser Kim T.
Reference250 articles.
1. Adams, G. L., Dworkin, R. J., & Rosenberg, S. D. (1984). Diagnosis and pharmacotherapy issues in the care of Hispanics in the public sector. American Journal of Psychiatry, 141, 970–974.
2. Alvir, J. M. J., Lieberman, J. A., & Safferman, A. Z. (1995). Do white-cell count spikes predict agranulocytosis in clozapine recipients? Psychopharmacology Bulletin, 31, 311–314.
3. Amador, X. F, & Gorman, J. M. (1998). Psychopathologic domains and insight in schizophrenia. Psychiatric Clinics of North America, 21, 27–42.
4. Amador, X., Strauss, D., Yale, S., & Gorman, J. M. (1991). Awareness of illness in schizophrenia. Schizophrenia Bulletin, 17, 113–132.
5. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV). Washington, DC: Author.